Ban on oxytocin likely to be lifted

The ban was effected citing its misuse in the dairy sector

August 02, 2018 09:55 pm | Updated August 03, 2018 12:59 am IST - Thiruvananthapuram

Gynaecologists and obstetricians across the country can now exhale in relief: the Drug Technical Advisory Board (DTAB) has recommended to the Union Ministry of Health and Family Welfare that the ban on the retail sale of the life-saving drug, oxytocin, may be lifted.

The DTAB, in its meeting on July 25, recommended that the Health and Family Welfare Ministry’s notification on April 27, banning retail sale of the drug formulation, oxytocin, may be amended and that its sale and distribution for human use, under the Drugs and Cosmetics Act 1940 and Rules 1945, be continued.

The ban had been imposed citing the serious misuse of oxytocin in the dairy sector.

While it recommended lifting of the ban, the DTAB has not said anything about the Ministry’s decision (vide notification dated June 27) that only a single PSU — Karnataka Antibiotics and Pharmaceuticals Ltd. — could manufacture and supply the drug across the country.

‘Welcome move’

The DTAB recommendation has brought immense relief to gynaecologists and obstetricians, who had said that the ban on retail sale of the drug could affect its availability in hospitals and clinics in rural areas, where more women were likely to bleed to death post-partum in labour rooms.

“It is certainly a welcome decision. But the fact that a single PSU, KAPL, which has never manufactured oxytocin, continues to hold the monopoly in the manufacture, distribution and sale of an essential drug like this, raises important questions. Also, nothing has been said about the pricing of oxytocin by KAPL — at ₹17.78 (including GST) per five IU vial — when several private pharma firms were earlier supplying it for as low as ₹4.82. Several concerns remain still,” a senior gynaecologist here said.

“In effect, the lower priced and time-tested oxytocin brands of private pharma companies will be replaced with the costly brand of KAPL, in the name of misuse of oxytocin,” points out K. V. Babu, a physician and public health activist in Kerala.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.